Pulmonary Hypertension

April 21, 2015November 5, 2015

Gene Mutation in Cattle Leads to Human Pulmonary Hypertension Insights

Cattle and humans may have diverged from the evolutionary tree a while back in time, but genetic mutations in cattle may lead to pulmonary hypertension such as that seen in ... Read more

April 20, 2015November 5, 2015

Salidroside Herb Found To Reduce Chronic Hypoxia-induced Pulmonary Arterial Hypertension

News, Pulmonary Hypertension

According to a recent study published in the Journal of Molecular and Cellular Cardiology, an herb called Salidroside can reduce chronic hypoxia-induced Pulmonary arterial hypertension by promoting PASMCs apoptosis via an A2aR related ... Read more

April 15, 2015November 5, 2015

FDA Grants Reata Pharmaceuticals’ Bardoxolone Methyl Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension

News, Pulmonary Hypertension

Reata Pharmaceuticals, Inc., an Irving, Texas-based biopharmaceutical company developing transcription-regulating activity drugs called antioxidant inflammation modulators (AIMs), recently announced that the Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) ... Read more

April 15, 2015November 5, 2015

Pulmonary Hypertension Association Joins Donate Life Month this April

News, Pulmonary Hypertension

April is Donate Life Month, which celebrates the importance of donating organs. The Pulmonary Hypertension Association (PHA) is joining the cause and advocating for increased organ donation in order to benefit ... Read more

April 13, 2015November 5, 2015

Pulmonary Hypertension Association Rated Four-Star Charity

News, Pulmonary Hypertension

The Pulmonary Hypertension Association (PHA) has been rated a four-star organization for the 12th consecutive year by Charity Navigator. The evaluator of U.S. charities awarded the rating to PHA due to its ... Read more

April 9, 2015November 5, 2015

Patients Undergoing Hemodialysis Have Higher Prevalence of Pulmonary Hypertension and Heart Disease

News, Pulmonary Hypertension

Researchers from Korea University Anam Hospital found a higher prevalence of pulmonary hypertension (PHT) associated with higher rates of major cardiovascular events in end-stage renal disease (ESRD) patients undergoing hemodialysis. ... Read more

April 8, 2015November 5, 2015

Ongoing Clinical Trial Testing Molecular Imaging Agent for Pulmonary Hypertension Diagnosis

News, Pulmonary Hypertension

A team led by researchers at the Montreal Heart Institute in Canada is currently recruiting participants for a clinical trial designed to assess the safety and efficacy of a new ... Read more

April 7, 2015November 5, 2015

Actavis Files ANDA for Generic Ambrisentan Tablets for PAH

News, Pulmonary Hypertension

Actavis recently confirmed that the company has filed an Abbreviated New Drug Application (ANDA) with the United States Food and Drug Administration (FDA) seeking approval to commercialize their formulation of Ambrisentan Tablets (5 and 10 mg). ... Read more

April 6, 2015November 5, 2015

Newly Discovered Molecular Mechanism May Be Cause of Pulmonary Hypertension

News, Pulmonary Hypertension

Researchers from Brigham and Women’s Hospital recently released findings from a study in which they have potentially uncovered the physiological mechanism leading to the development of Pulmonary Hypertension (PH). The ... Read more

April 1, 2015November 5, 2015

Pulmonary Hypertension Association Supporting Patients’ Access to Treatments Act

News, Pulmonary Hypertension

The Pulmonary Hypertension Association (PHA) is fully supporting the Patients’ Access to Treatments Act (PATA), which was recently introduced in the House of Representatives by Lois Capps (D-CA) and David B. ... Read more